About
Starlight Cardiovascular is developing much needed tools and devices to treat pediatric Congenital Heart Defects (CHDs). Approximately 1.3 million babies are born each year with a CHD. Most of the tools used to treat these children were designed for adult conditions and anatomy, limiting their utility for pediatric patients. Starlight Cardiovascular is developing a portfolio of devices designed and tested specifically for pediatric CHD with the goals of improving morbidity, mortality, and access to care.
Technologies
GmailGoogle AppsMobile FriendlySquarespace ECommerceRemote
Keywords
neonatal stent developmentchd access toolspediatric catheterization devicesmedical deviceshealthcare equipment & suppliesconsultingsmall vessel treatment devicesdevice testing for childrenpediatric cardiology toolsmanufacturingchd treatment devicespediatric device innovationpediatric cardiovascular devicesneonatal-sized stentspediatric intervention devicesb2bmedical technologyneonatal circulatory systemmedical equipment and supplies manufacturingpediatric healthcaremedical device developmentpediatric congenital heart diseaseneonatal stenthealthcare technologypediatric cardiology innovationhealthcarehospital & health caremechanical or industrial engineeringhealth carehealth
Company Information
- Employees14
- Founded2020
- Annual Revenue$500000
- Total Funding$9480000
Location
9710 Scranton Rd, San Diego, California, United States, 92121-1711
